3.40 USD
▼-0.09-2.58%
盘后 3.35 -1.47%
2026-09-15
市值
$144.93M
市盈率
—
EPS
-0.78
股息率
—
52 周区间
1.62 – 5.06
成交量
1.26M
Beta
2.19
目标价
38.25
52W 低 1.6252W 高 5.06
价格走势
公司简介
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for in...